Reanalysis of two studies with contrasting results on the association between statin use and fracture risk: the General Practice Research Database.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  International Journal of Epidemiology

• Publication date

  2006-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/IJE/DYL147PMID 17053011
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• MRC/BHF heart protection study of cholesterol lowering with simvastatin in 20536 high-risk individuals : a randomised placebo-controlled trial.

  2008cited by this paper
• Lipid-lowering therapy with statins in high-risk elderly patients: the treatment-risk paradox.

  2004cited by this paper
• Commentary: hormone replacement therapy and coronary heart disease: four lessons.

  2004cited by this paper
• Randomized Trial of Effect of Alendronate Continuation Versus Discontinuation in Women With Low BMD: Results From the Fracture Intervention Trial Long‐Term Extension

  2004cited by this paper
• Use of statins and fracture: results of 4 prospective studies and cumulative meta-analysis of observational studies and controlled trials.

  2004cited by this paper
• Evaluating medication effects outside of clinical trials: new-user designs.

  2003cited by this paper
• Análisis crítico de un artículo Las estatinas reducen la morbi-mortalidad en pacientes de alto riesgo cardiovascular: Heart Protection Study Collaborative Group. (HPS). Lancet 2002; 360: 7-22.

  2003cited by this paper
• Postmenopausal Hormone Replacement Therapy and the Primary Prevention of Cardiovascular Disease

  2002cited by this paper
• MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial. Commentary

  2002cited by this paper
• Lipid-lowering agents and the risk of hip fracture in a Medicaid population

  2002cited by this paper
• MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial.

  2002cited by this paper
• Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS): Efficacy and Tolerability of Long-Term Treatment with Lovastatin in Women

  2001cited by this paper
• Use of statins and risk of fractures.

  2001cited by this paper
• Paradoxical Relations of Drug Treatment with Mortality in Older Persons

  2001cited by this paper
• Nitrogen-bisphosphonates block retinoblastoma phosphorylation and cell growth by inhibiting the cholesterol biosynthetic pathway in a keratinocyte model for esophageal irritation.

  2001cited by this paper
• Statins and fracture risk.

  2001cited by this paper
• Statins and fracture risk.

  2001cited by this paper
• Effect of pravastatin on frequency of fracture in the LIPID study: secondary analysis of a randomised controlled trial. Long-term Intervention with Pravastatin in Ischaemic Disease.

  2001cited by this paper
• Statin drugs and the risk of fracture.

  2000cited by this paper
• Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS): Baseline Characteristics and Comparison with USA Population

  2000cited by this paper
• HMG-CoA reductase inhibitors and the risk of fractures.

  2000cited by this paper
• Socioeconomic Status, Marital Status and Hip Fracture Risk: A Population-Based Case–Control Study

  2000cited by this paper
• Farnesyl pyrophosphate synthase is the molecular target of nitrogen-containing bisphosphonates.

  1999cited by this paper
• Stimulation of bone formation in vitro and in rodents by statins.

  1999cited by this paper
• Drug exposure risk windows and unexposed comparator groups for cohort studies in pharmacoepidemiology

  1998cited by this paper
• Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group.

  1996cited by this paper
• A study of the effects of exposure misclassification due to the time-window design in pharmacoepidemiologic studies.

  1994cited by this paper
• Odds ratio inference from stratified samples

  1989cited by this paper

• The study of total hip arthroplasty outcomes among statin users in Sina Hospital, Iran

  2025cites this paper
• Medicine utilization studies in Australian individual‐level dispensing data: A blinded, multi‐center replicated analysis

  2024cites this paper
• Reporting to Improve Reproducibility and Facilitate Validity Assessment for Healthcare Database Studies V1.0.

  2023cites this paper
• STaRT-RWE: structured template for planning and reporting on the implementation of real world evidence studies

  2021cites this paper
• Response to: ‘Correspondence on ‘Concomitant use of oral glucocorticoids and proton pump inhibitors and risk of osteoporotic fractures among patients with rheumatoid arthritis: a population-based cohort study’ by Gong and Zhang and Lin et al

  2021cites this paper
• How pharmacoepidemiology networks can manage distributed analyses to improve replicability and transparency and minimize bias

  2020cites this paper
• National Database Research in Head and Neck Reconstructive Surgery: A Call for Increased Transparency and Reproducibility

  2020cites this paper
• Comparing risk of major bleeding between users of different oral anticoagulants in patients with nonvalvular atrial fibrillation

  2020cites this paper
• Quality of reporting of drug exposure in pharmacoepidemiological studies

  2020cites this paper
• Transparency in real‐world evidence (RWE) studies to build confidence for decision‐making: Reporting RWE research in diabetes

  2020cites this paper
• Bias in pharmacoepidemiologic studies using secondary health care databases: a scoping review

  2019cites this paper
• Quantifying how small variations in design elements affect risk in an incident cohort study in claims

  2019cites this paper
• Limitations for health research with restricted data collection from UK primary care

  2019cites this paper
• Possible Sources of Bias in Primary Care Electronic Health Record Data Use and Reuse

  2018cites this paper
• Pharmacoepidemiological approaches for population-based hypothesis testing

  2018cites this paper
• Improving reproducibility by using high-throughput observational studies with empirical calibration

  2018cites this paper
• An Evaluation of the Use of a Clinical Research Data Warehouse and I2b2 Infrastructure to Facilitate Replication of Research

  2018cites this paper
• Reporting to Improve Reproducibility and Facilitate Validity Assessment for Healthcare Database Studies V1.0

  2017cites this paper
• Reporting to Improve Reproducibility and Facilitate Validity Assessment for Healthcare Database Studies V1.0.

  2017cites this paper
• Identifying and appraising promising sources of UK clinical, health and social care data for use by NICE

  2016cites this paper
• Use of incretin agents and risk of pancreatic cancer: a population‐based cohort study

  2016cites this paper
• The IMI PROTECT project: purpose, organizational structure, and procedures

  2016cites this paper
• Statins and Risk of Lower Limb Revision Surgery: The Influence of Differences in Study Design Using Electronic Health Records From the United Kingdom and Denmark

  2016cites this paper
• Field-wide meta-analyses of observational associations can map selective availability of risk factors and the impact of model specifications.

  2016cites this paper
• The identification of incident cancers in UK primary care databases: a systematic review

  2015cites this paper
• Smoke-free legislation and the incidence of paediatric respiratory infections and wheezing/asthma: interrupted time series analyses in the four UK nations

  2015cites this paper
• Use of Dipeptidyl-Peptidase-4 Inhibitors and the Risk of Pneumonia: A Population-Based Cohort Study

  2015cites this paper
• Association of Statins and Risk of Fractures in a Military Health System

  2014cites this paper
• Unintended effects of statins from observational studies in the general population: systematic review and meta-analysis

  2014cites this paper
• Bridging Differences in Outcomes of Pharmacoepidemiological Studies: Design and First Results of the PROTECT Project

  2014cites this paper
• Lost in Translation: Exposure Misclassification when Relying on Days Supply in Pharmacy Claims Data

  2014cites this paper
• Complications of hip and knee replacement surgery: a pharmaco-epidemiological approach

  2014cites this paper
• Population-based studies on risk of fracture in patients with neurological disorders

  2014cites this paper
• Real-life data and learning from practice to advance innovation

  2013cites this paper
• Multiple sclerosis and fracture risk: traditional meta- analysis versus mega-analysis of individual patient data

  2013cites this paper
• Pioglitazone and bladder cancer: two studies, same database, two answers.

  2013cites this paper
• Statin use and reduced cancer-related mortality

  2013cites this paper
• Does design matter? Systematic evaluation of the impact of analytical choices on effect estimates in observational studies

  2013cites this paper
• Desideratum for Evidence Based Epidemiology

  2013cites this paper
• Use of biguanides and the risk of colorectal cancer: a register-based cohort study.

  2013cites this paper
• Statin use and reduced cancer-related mortality.

  2012cites this paper
• Epidemiology - Current Perspectives on Research and Practice

  2012cites this paper
• Overview of Pharmacoepidemiological Databases in the Assessment of Medicines Under Real-Life Conditions

  2012cites this paper
• Glucose-lowering agents and the patterns of risk for cancer: a study with the General Practice Research Database and secondary care data

  2012cites this paper
• Non-steroidal anti-inflammatory drugs and the risk of Clostridium difficile-associated disease.

  2012cites this paper
• Insulin use and cancer risk in patients with type 2 diabetes: a systematic review and meta-analysis of observational studies.

  2012cites this paper
• Heart drugs that affect bone.

  2012cites this paper
• Fracture risk before and after total hip replacement in patients with osteoarthritis: potential benefits of bisphosphonate use.

  2011cites this paper
• Bisphosphonates and esophageal cancer—a pathway through the confusion

  2011cites this paper
• Knee Arthroplasty and Risk of Hip Fracture: A Population-Based, Case–Control Study

  2011cites this paper
• Principles of Drug Literature Evaluation for Observational Study Designs

  2011cites this paper
• The implications of propensity score variable selection strategies in pharmacoepidemiology: an empirical illustration

  2011cites this paper
• Risk of Death and Cardiovascular Outcomes with Thiazolidinediones: A Study with the General Practice Research Database and Secondary Care Data

  2011cites this paper
• Is there an anti-inflammatory effect of statins in rheumatoid arthritis? Analysis of a large routinely collected claims database.

  2010cites this paper
• Proton pump inhibitors, fracture risk and selection bias: three studies, same database, two answers

  2010cites this paper
• Two studies, same data source, two answers

  2010cites this paper
• Simvastatin locally applied from a biodegradable coating of osteosynthetic implants improves fracture healing comparable to BMP-2 application.

  2009cites this paper
• Effect of statins on a wide range of health outcomes: a cohort study validated by comparison with randomized trials.

  2009cites this paper
• Use of organic nitrates and the risk of hip fracture: a population-based case-control study.

  2009cites this paper
• Estimating the effect of current, previous and never use of drugs in studies based on prescription registries

  2009cites this paper
• Risk of Hip/Femur Fracture After Stroke: A Population-Based Case-Control Study

  2009cites this paper
• Mapping the prescriptiome to fractures in men—a national analysis of prescription history and fracture risk

  2009cites this paper
• Proactive Postmarketing Surveillance: Overview and Lessons Learned from Medication Safety Research in the Veterans Health Administration

  2008cites this paper
• The effect of statin use on incident immune-mediated and infectious conditions among U.S. veterans

  2008cites this paper
• A pilot study to test multiple medication usage and driving functioning

  2008cites this paper
• Statins and fracture risk. A systematic review

  2007cites this paper
• Commentary: statins and fracture--why the confusion?

  2006cites this paper
• Statistics: Analysis and Presentation of Safety Data

  2005cites this paper